See more : Emerita Resources Corp. (EMO.V) Income Statement Analysis – Financial Results
Complete financial analysis of Tate & Lyle plc (TATYY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tate & Lyle plc, a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- IDEX Biometrics ASA (IDBA) Income Statement Analysis – Financial Results
- Kissei Pharmaceutical Co., Ltd. (KSPHF) Income Statement Analysis – Financial Results
- Kiplin Metals Inc. (ALDVF) Income Statement Analysis – Financial Results
- Visco Trade Associates Limited (VISCO.BO) Income Statement Analysis – Financial Results
- Twelve Seas Investment Company II (TWLVW) Income Statement Analysis – Financial Results
Tate & Lyle plc (TATYY)
About Tate & Lyle plc
Tate & Lyle PLC, together with its subsidiaries, provides ingredients and solutions to the food, beverage, and other industries in the United States, the United Kingdom, other European countries, and internationally. It operates through three segments: Food & Beverage Solutions, Sucralose, and Primary Products. The company offers texturants; nutritive sweeteners, such as high fructose corn syrup and dextrose; health and wellness ingredients; and stabilizers. It also provides industrial starches for paper, packaging, and industrial adhesives; acidulants, such as citric acid; and commodities comprising corn gluten feed and meal for animal nutrition, as well as corn oil and ethanol. In addition, the company engages in the treasury and insurance businesses; and provision of research and development services. Tate & Lyle PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.
Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1.65B | 1.75B | 1.38B | 1.21B | 2.88B | 2.76B | 2.71B | 2.75B | 2.36B | 2.34B | 3.15B | 3.26B | 3.09B | 2.72B | 2.53B | 3.55B | 2.87B | 3.23B | 3.47B | 3.34B | 2.58B | 3.17B | 3.94B | 3.83B | 0.00 | 4.12B | 4.35B | 4.88B | 4.25B | 4.07B | 3.70B | 3.29B | 3.22B | 3.39B | 3.36B | 2.09B | 1.70B | 1.65B | 1.63B |
Cost of Revenue | 796.00M | 1.26B | 1.04B | 908.00M | 1.99B | 1.52B | 1.51B | 1.60B | 1.40B | 1.44B | 2.19B | 2.28B | 2.16B | 1.81B | 1.25B | 2.03B | 1.54B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 235.30M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 851.00M | 496.00M | 339.00M | 303.00M | 892.00M | 1.24B | 1.20B | 1.15B | 956.00M | 906.00M | 962.00M | 975.00M | 933.00M | 912.00M | 1.29B | 1.53B | 1.32B | 3.23B | 3.47B | 3.34B | 2.58B | 3.17B | 3.94B | 3.83B | 0.00 | 4.12B | 4.12B | 4.88B | 4.25B | 4.07B | 3.70B | 3.29B | 3.22B | 3.39B | 3.36B | 2.09B | 1.70B | 1.65B | 1.63B |
Gross Profit Ratio | 51.67% | 28.33% | 24.65% | 25.02% | 30.95% | 44.90% | 44.17% | 41.81% | 40.59% | 38.70% | 30.57% | 29.94% | 30.21% | 33.53% | 50.81% | 42.95% | 46.18% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% | 100.00% | 94.59% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 44.00M | 46.00M | 41.00M | 42.00M | 34.00M | 36.00M | 35.00M | 37.00M | 29.00M | 32.00M | 33.00M | 32.00M | 29.00M | 25.00M | 26.00M | 28.00M | 29.00M | 15.00M | 21.00M | 20.00M | 17.00M | 18.00M | 17.00M | 13.00M | 0.00 | 16.30M | 22.40M | 23.60M | 29.00M | 29.80M | 22.20M | 18.10M | 15.20M | 12.20M | 15.90M | 10.20M | 5.70M | 4.50M | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.42B | -277.00M | -319.00M | -355.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -2.19B | 496.00M | 480.00M | 478.00M | 442.00M | 427.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 265.00M | 224.00M | 132.00M | 104.00M | 541.00M | 222.00M | 226.00M | 219.00M | 161.00M | 123.00M | 442.00M | 427.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Expenses | 335.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -7.00M | -6.00M | -8.00M | 4.00M | 71.00M | 5.00M | -4.00M | -19.00M | -3.00M | 4.00M | 2.91B | -3.00M | -3.00M | -57.00M | 26.00M | -13.00M | -298.00M | 0.00 | 11.20M | 3.90B | -3.00M | -2.30M | -900.00K | -700.00K | -3.90M | 272.50M | 270.40M | 259.90M | 127.30M | 88.90M | 71.90M | 1.63B |
Operating Expenses | 644.00M | 270.00M | 173.00M | 146.00M | 575.00M | 971.00M | 885.00M | 894.00M | 808.00M | 858.00M | 630.00M | 627.00M | 2.74B | 2.43B | 2.34B | 3.28B | 2.61B | 2.90B | 3.15B | 3.12B | 2.37B | 2.96B | 3.78B | 3.35B | 0.00 | 3.91B | 4.08B | 4.58B | 3.88B | 3.77B | 3.44B | 3.06B | 3.22B | 3.39B | 3.36B | 2.09B | 1.70B | 1.65B | 1.63B |
Cost & Expenses | 1.44B | 1.53B | 1.21B | 1.05B | 2.57B | 2.49B | 2.40B | 2.50B | 2.21B | 2.29B | 2.82B | 2.91B | 2.74B | 2.43B | 2.34B | 3.28B | 2.61B | 2.90B | 3.15B | 3.12B | 2.37B | 2.96B | 3.78B | 3.35B | 0.00 | 3.91B | 4.08B | 4.58B | 3.88B | 3.77B | 3.44B | 3.06B | 3.22B | 3.39B | 3.36B | 2.09B | 1.70B | 1.65B | 1.63B |
Interest Income | 19.00M | 12.00M | 1.00M | 1.00M | 5.00M | 26.00M | 26.00M | 24.00M | 22.00M | 23.00M | 2.00M | 1.00M | 8.00M | 3.00M | 2.00M | 10.00M | 38.00M | 50.00M | 45.00M | 34.00M | 31.00M | 34.00M | 47.00M | 32.00M | 0.00 | 32.00M | 27.70M | 32.50M | 24.40M | 32.20M | 38.80M | 34.90M | 29.60M | 34.30M | 41.50M | 29.40M | 13.30M | 17.20M | 0.00 |
Interest Expense | 25.00M | 29.00M | 23.00M | 22.00M | 33.00M | 31.00M | 28.00M | 28.00M | 25.00M | 32.00M | 37.00M | 97.00M | 32.00M | 50.00M | 74.00M | 59.00M | 78.00M | 83.00M | 76.00M | 56.00M | 50.00M | 60.00M | 102.00M | 99.00M | 0.00 | 99.30M | 88.60M | 89.80M | 78.30M | 72.20M | 85.90M | 82.80M | 79.30M | 95.60M | 111.70M | 48.70M | 19.00M | 16.10M | 0.00 |
Depreciation & Amortization | 94.00M | 95.00M | 80.00M | 97.00M | 172.00M | 152.00M | 154.00M | 149.00M | 115.00M | 109.00M | 118.00M | 108.00M | 103.00M | 109.00M | 119.00M | 132.00M | 115.00M | 93.00M | 127.00M | 132.00M | 114.00M | 118.00M | 129.00M | 132.00M | 0.00 | 134.60M | 144.70M | 125.40M | 135.20M | 127.00M | 103.80M | 84.20M | 78.00M | 81.30M | 91.10M | 40.00M | 22.50M | 21.90M | 0.00 |
EBITDA | 345.00M | 321.00M | 168.00M | 292.00M | 501.00M | 448.00M | 436.00M | 399.00M | 286.00M | 276.00M | 353.00M | 443.00M | 455.00M | 404.00M | 77.00M | 304.00M | 375.00M | 429.00M | 217.00M | 395.00M | 380.00M | 357.00M | 382.00M | 370.00M | 0.00 | 399.30M | 392.60M | 491.50M | 524.60M | 473.00M | 412.20M | 356.50M | 388.10M | 394.90M | 403.20M | 208.80M | 133.50M | 119.50M | 0.00 |
EBITDA Ratio | 20.95% | 18.33% | 17.89% | 20.97% | 16.97% | 16.26% | 16.09% | 14.49% | 12.14% | 11.79% | 14.08% | 13.64% | 14.73% | 14.82% | 12.32% | 10.84% | 14.13% | 14.33% | 14.11% | 11.47% | 14.84% | 11.21% | 9.69% | 9.67% | 0.00% | 9.76% | 10.80% | 9.92% | 12.88% | 11.56% | 11.05% | 10.89% | 12.05% | 11.64% | 12.00% | 10.00% | 7.85% | 7.27% | 0.00% |
Operating Income | 207.00M | 226.00M | 166.00M | 157.00M | 317.00M | 296.00M | 282.00M | 250.00M | 171.00M | 167.00M | 325.00M | 336.00M | 404.00M | 303.00M | -44.00M | 164.00M | 224.00M | 302.00M | 47.00M | 229.00M | 206.00M | 224.00M | 172.00M | 151.00M | 0.00 | 202.80M | 202.80M | 309.10M | 348.10M | 303.00M | 259.30M | 233.10M | 233.10M | 313.60M | 312.10M | 168.80M | 111.00M | 97.70M | 0.00 |
Operating Income Ratio | 12.57% | 12.91% | 12.07% | 12.96% | 11.00% | 10.74% | 10.41% | 9.08% | 7.26% | 7.13% | 10.33% | 10.32% | 13.08% | 11.14% | -1.74% | 4.62% | 7.81% | 9.36% | 1.36% | 6.86% | 7.98% | 7.07% | 4.36% | 3.95% | 0.00% | 4.93% | 4.66% | 6.34% | 8.20% | 7.44% | 7.01% | 7.08% | 7.24% | 9.24% | 9.29% | 8.08% | 6.53% | 5.94% | 0.00% |
Total Other Income/Expenses | 19.00M | -44.00M | -25.00M | -26.00M | -54.00M | -56.00M | -4.00M | -29.00M | -51.00M | -150.00M | 39.00M | -35.00M | -25.00M | -58.00M | -72.00M | -51.00M | -42.00M | -49.00M | -33.00M | -24.00M | 18.00M | -37.00M | -13.00M | -341.00M | 0.00 | -37.40M | -112.60M | -32.80M | -37.00M | -29.20M | -36.80M | -43.60M | -2.30M | -95.60M | -111.70M | -48.70M | -19.00M | -16.20M | 76.70M |
Income Before Tax | 226.00M | 176.00M | 42.00M | 90.00M | 268.00M | 240.00M | 286.00M | 233.00M | 126.00M | 25.00M | 290.00M | 309.00M | 379.00M | 245.00M | -116.00M | 113.00M | 182.00M | 253.00M | 14.00M | 205.00M | 224.00M | 152.00M | 159.00M | -190.00M | 0.00 | 165.40M | 159.30M | 276.30M | 311.10M | 273.80M | 222.50M | 189.50M | 230.80M | 218.00M | 200.40M | 120.10M | 92.00M | 81.50M | 76.70M |
Income Before Tax Ratio | 13.72% | 10.05% | 3.05% | 7.43% | 9.30% | 8.71% | 10.55% | 8.46% | 5.35% | 1.07% | 9.22% | 9.49% | 12.27% | 9.01% | -4.58% | 3.18% | 6.35% | 7.84% | 0.40% | 6.14% | 8.68% | 4.80% | 4.03% | -4.96% | 0.00% | 4.02% | 3.66% | 5.66% | 7.32% | 6.72% | 6.02% | 5.75% | 7.17% | 6.43% | 5.96% | 5.75% | 5.41% | 4.95% | 4.71% |
Income Tax Expense | 47.00M | 25.00M | 16.00M | 1.00M | 51.00M | 59.00M | 23.00M | 22.00M | 5.00M | 21.00M | 45.00M | 49.00M | 72.00M | 49.00M | -95.00M | 19.00M | 76.00M | 88.00M | 60.00M | 55.00M | 69.00M | 57.00M | 39.00M | 40.00M | 0.00 | 44.00M | 50.30M | 70.10M | 84.50M | 73.70M | 55.00M | 49.80M | 64.80M | 63.50M | 65.20M | 36.20M | 28.10M | 32.60M | 76.70M |
Net Income | 188.00M | 190.00M | 236.00M | 253.00M | 245.00M | 181.00M | 265.00M | 256.00M | 121.00M | 4.00M | 273.00M | 277.00M | 305.00M | 163.00M | 15.00M | 65.00M | 194.00M | 214.00M | -30.00M | 146.00M | 154.00M | 97.00M | 118.00M | -236.00M | 0.00 | 124.00M | 101.70M | 174.00M | 198.30M | 171.10M | 149.20M | 116.10M | 143.70M | 176.90M | 113.10M | 70.20M | 69.90M | 26.80M | 0.00 |
Net Income Ratio | 11.41% | 10.85% | 17.16% | 20.89% | 8.50% | 6.57% | 9.78% | 9.30% | 5.14% | 0.17% | 8.67% | 8.51% | 9.88% | 5.99% | 0.59% | 1.83% | 6.77% | 6.64% | -0.87% | 4.37% | 5.97% | 3.06% | 2.99% | -6.17% | 0.00% | 3.01% | 2.34% | 3.57% | 4.67% | 4.20% | 4.03% | 3.52% | 4.46% | 5.21% | 3.37% | 3.36% | 4.11% | 1.63% | 0.00% |
EPS | 0.44 | 0.47 | 0.59 | 0.64 | 0.62 | 0.46 | 0.67 | 0.64 | 0.30 | 0.01 | 2.71 | 2.73 | 3.00 | 1.62 | 0.15 | 0.66 | 1.88 | 2.03 | -0.29 | 1.43 | 1.52 | 0.95 | 1.15 | -2.33 | 0.00 | 1.23 | 1.03 | 1.76 | 1.90 | 1.65 | 1.44 | 1.13 | 1.48 | 2.57 | 1.75 | 1.17 | 1.17 | 0.45 | 0.00 |
EPS Diluted | 0.47 | 0.46 | 0.59 | 0.63 | 0.61 | 0.45 | 0.66 | 0.63 | 0.30 | 0.01 | 2.71 | 2.73 | 3.00 | 1.62 | 0.15 | 0.66 | 1.88 | 2.03 | -0.29 | 1.43 | 1.52 | 0.95 | 1.15 | -2.33 | 0.00 | 1.23 | 1.03 | 1.76 | 1.90 | 1.65 | 1.44 | 1.13 | 1.48 | 2.57 | 1.75 | 1.17 | 1.17 | 0.45 | 0.00 |
Weighted Avg Shares Out | 423.42M | 404.10M | 398.66M | 397.89M | 397.89M | 396.51M | 396.26M | 397.80M | 397.97M | 401.14M | 100.82M | 101.46M | 101.64M | 100.66M | 97.93M | 98.53M | 102.94M | 105.21M | 102.15M | 102.11M | 101.23M | 102.06M | 102.79M | 101.27M | 118.15M | 100.59M | 98.99M | 98.67M | 104.40M | 103.87M | 103.37M | 102.79M | 97.11M | 68.79M | 64.54M | 60.26M | 59.66M | 59.40M | 69.30M |
Weighted Avg Shares Out (Dil) | 404.20M | 411.40M | 403.20M | 402.34M | 403.37M | 402.43M | 402.86M | 403.89M | 400.89M | 401.14M | 100.82M | 101.46M | 101.64M | 100.66M | 97.93M | 98.53M | 102.94M | 105.21M | 102.15M | 102.11M | 101.23M | 102.06M | 102.79M | 101.27M | 118.15M | 100.59M | 98.99M | 98.67M | 104.40M | 103.87M | 103.37M | 102.79M | 97.11M | 68.79M | 64.54M | 60.26M | 59.66M | 59.40M | 69.30M |
Tate & Lyle and Whitworth sugar makers' deal facing block
Tate & Lyle plc (TATYF) Q3 2024 Sales/Trading Statement Call Transcript
Tate & Lyle sees lower revenue as demand softens
Will Tate & Lyle sales shrug off rise of weight loss drugs?
Tate & Lyle, PLC (TATYF) Q3 2023 Earnings Call Transcript
TATE & LYLE EARNS PRIME ESG CORPORATE RATING FROM ISS
Tate & Lyle sales threatened by weight loss products
Tate & Lyle climbs on 'reassuring update'
Tate & Lyle secures price increases for 2023 to cover higher input costs
Tate & Lyle sees full-year adjusted profit rising in line with views after revenue boost
Source: https://incomestatements.info
Category: Stock Reports